Brief: Iovance Biotherapeutics Enters Amended Sale Agreement With Jefferies
Aug 22 (Reuters) - Iovance Biotherapeutics Inc IOVA.O: IOVANCE BIOTHERAPEUTICS INC - ENTERS AMENDED SALE AGREEMENT WITH JEFFERIES - SEC FILING IOVANCE BIOTHERAPEUTICS INC - MAY SELL UP TO $350 MILLION OF COMMON STOCK - SEC FILING Source text: [ID:n0001104659-25-081953] Further company coverage: IOVA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iovance Biotherapeutics
See all newsBrief: Iovance Biotherapeutics Reports Inducement Grants
US RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Brief: Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., As Chief Medical Officer
Iovance hits two-year high after raising annual revenue forecast
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies